236
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECausation and Prevention

A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia

, &
Pages 312-322 | Published online: 28 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matteo Santoni, Michele De Tursi, Alessandra Felici, Giovanni Lo Re, Riccardo Ricotta, Enzo Maria Ruggeri, Roberto Sabbatini, Daniele Santini, Vanja Vaccaro & Michele Milella. (2013) Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. Expert Review of Anticancer Therapy 13:6, pages 697-709.
Read now
Hyun Young Woo, Jeong Heo, Ki Tae Yoon, Gwang Ha Kim, Dae Hwan Kang, Geun Am Song & Mong Cho. (2012) Clinical course of sorafenib treatment in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 47:7, pages 809-819.
Read now

Articles from other publishers (11)

Jenny L. Firkins, Robin Tarter, Martha Driessnack & Lissi Hansen. (2021) A closer look at quality of life in the hepatocellular carcinoma literature. Quality of Life Research 30:6, pages 1525-1535.
Crossref
Emma Bergfelt Lennmyr, Karin Karlsson, Marie Abrahamsson, Fereshte Ebrahim, Anna Lübking, Martin Höglund, Gunnar Juliusson & Heléne Hallböök. (2020) Introducing patient‐reported outcome in the acute leukemia quality registries in Sweden. European Journal of Haematology 104:6, pages 571-580.
Crossref
Kun Zhou, Xiaoyu Luo, Yu Wang, Dachun Cao & Gang Sun. (2017) MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 93, pages 1025-1032.
Crossref
Mohmad Hussain Mir, Khalid Hamid Changal, Shiekh Aejaz Aziz, Gull Mohammad Bhat & Abdul Rashid Lone. (2016) Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?. International Urology and Nephrology 48:11, pages 1811-1816.
Crossref
E. Nilsson, L. Orwelius & M. Kristenson. (2016) Patient-reported outcomes in the Swedish National Quality Registers. Journal of Internal Medicine 279:2, pages 141-153.
Crossref
Kathrin Damm, Nicole Roeske & Christian Jacob. (2013) Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Economics Review 3:1.
Crossref
Chris L. Pashos, Christopher R. Flowers, Neil E. Kay, Mark Weiss, Nicole Lamanna, Charles Farber, Susan Lerner, Jeff Sharman, David Grinblatt, Ian W. Flinn, Mark Kozloff, Arlene S. Swern, Thomas K. Street, Kristen A. Sullivan, Gale Harding & Zeba M. Khan. (2013) Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Supportive Care in Cancer 21:10, pages 2853-2860.
Crossref
Roberto SabbatiniCinizia Ortega, Giuseppe Procopio, Cristina Masini, Enzo Galligioni & Camillo Porta. (2013) Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor. Future Oncology 9:6, pages 831-843.
Crossref
Kathrin Damm, Christian Jacob, Thomas Mittendorf & J. -Matthias Graf von der Schulenburg. (2013) Lebensqualitätsmessung in klinischen Studien beim Lungenkarzinom — Übersicht anhand der Datenbank ClinicalTrials.govMeasuring Health Related Quality of Life in Lung Cancer Clinical Trials — An Overview of the Database ClinicalTrials.gov. PharmacoEconomics German Research Articles 10:1, pages 3-15.
Crossref
David Cella. (2011) Beyond Traditional Outcomes: Improving Quality of Life in Patients with Renal Cell Carcinoma. The Oncologist 16:S2, pages 23-31.
Crossref
Eric A. Singer, Gennady Bratslavsky, W. Marston Linehan & Ramaprasad Srinivasan. (2010) Targeted therapies for non-clear renal cell carcinoma. Targeted Oncology 5:2, pages 119-129.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.